APTOSE BIOSCIENCES INC (APS.CA) Stock Income Statement
Canada - TSX:APS - CA03835T4081 - Common Stock
2.36 CAD
+0.12 (+5.36%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 36.20M | 52.36M | 42.60M | 65.45M | 55.77M | |||
| Research and Development | 24.65M | 36.73M | 28.05M | 45.97M | 29.27M | |||
| Selling, General, and Administrative Expenses | 11.50M | 15.54M | 14.43M | 19.32M | 26.34M | |||
| Operating Income | -36.20M | -52.36M | -42.60M | -65.45M | -55.77M | |||
| Interest Income/Expense | 397.00K | 1.15M | 779.00K | 93.00K | 530.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -35.80M | -51.21M | -41.82M | -65.35M | -55.24M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -35.80M | -51.21M | -41.82M | -65.35M | -55.24M | |||
| EBITDA | -36.15M | -52.27M | -42.48M | -65.30M | -55.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -26.475900000000003 | -227.44 | -203.99 | -330.15 | -303.77 | |||
| Non GAAP EPS | -89.1 | -231.6 | -202.5 | -328.5 | -301.5 | |||
| Statistics | ||||||||
All data in USD